Hiroshima and Nagasaki: new doses, risks, and their implications.
This presentation summarizes the recent re-evaluations of the dose and risk of cancer among survivors of the atomic bombing of Hiroshima and Nagasaki. It addresses briefly their limitations, and describes some of their implications for the lifetime projection of the risk of a fatal cancer following exposure to ionizing radiation.
Schull
W J
WJ
Epidemiological Research Center, School of Public Health, University of Texas Health Science Center, Houston 77225.
Shimizu
Y
Y
Kato
H
H
D005260:Female; D006801:Humans; D007564:Japan; D008297:Male; D009381:Neoplasms, Radiation-Induced / Q000453:epidemiology / Q000209:etiology / Q000401:mortality; D009689:Nuclear Warfare; D011829:Radiation Dosage; D012307:Risk Factors